Thursday, April 12, 2012

Sexual Side Effect Warnings Added to Merck Drugs - Apr. 12, 2012

Having trouble viewing this email? View in Browser.
ClinicaSpace Focus
   Thursday, April 12, 2012 Advertising Information
subscriptions careernetwork news hotbeds careerfairs
Facebook  |  Linked In  |  Twitter  |  RSS  |  Subscribe

TOP SPONSOR

Reduce Risk and Maximize Potential in Ophthalmology Development

Ophthalmic study design and execution can be quite different than other therapeutic areas. Pharm-Olam's team has a proven track record of excellence in achieving trial objectives and can provide strategic, operational and consulting to sponsors for phase I to phase IV development.

The majority of our clinical staff in emerging markets are MDs or PhDs, including Ophthalmologists in strategic areas for clinical trials. The incidence of disorders and standards of treatment can vary widely, so let Pharm-Olam conduct a complimentary feasibility study specific to your protocol and study budgets to use in your resource planning.

Contact us at www.pharm-olam.com, info@pharm-olam.com, USA 1-713-559-7900, UK 44-0-1344-891121.
HeadHtml
•  Sexual Side Effect Warnings Added to Merck & Co., Inc. (MRK) Drugs More...
•  Prasco Laboratories Expands Authorized Generic Product Line with Vancocin® HCl Capsules More...
•  Nuvo Research Inc. (NRI.TO) Provides Pennsaid® Update More...
•  AstraZeneca PLC (AZN) Launches DUTOPROL™ (metoprolol succinate extended release/hydrochlorothiazide) Tablets for High Blood Pressure in U.S. More...
More Drug Product News
HeadHtml
•  Bayer AG (BAY.F) Seeks EU Approval of Xarelto for Pulmonary Embolism More...
More BLA/NDA/ANDA News
More IND News
More MAA News
HeadHtml
•  Gilead Sciences, Inc. (GILD) Bets on Hepatitis C Data to Justify Pharmasset, Inc. (VRUS)'s $10.8 Billion Deal More...
•  AVEO Pharmaceuticals, Inc. (AVEO) Announces Publication of Positive Tivozanib Phase 2 Clinical Trial Results in Journal of Clinical Oncology More...
•  AcelRx Pharmaceuticals Announces Initiation of Second Phase 3 Clinical Trial for ARX-01, the Sufentanil NanoTab® PCA System, for the Treatment of Acute Post-Operative Pain More...
More Phase III News
More Phase II News
More Phase I News
More Pre-Clinical News
More Post-Approval News
Featured Free Resource

Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing

This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set.

Request Now!
HeadHtml
•  Shift Work, Poor Sleep Linked With Obesity And Diabetes, Brigham and Women's Hospital Study More...
•  Vitamin D Does Not Seem to Boost Kids' Brainpower, Journal of Epidemiology and Community Health Reveals More...
•  Combined Vaccine Not Tied to Seizures in Older Kids, Kaiser Permanente Study More...
•  Study Shows New Option for Kids With Tough-to-Treat Leukemia, St. Jude Children's Research Hospital Study More...
•  Trouble Coping With the Unfamiliar as You Age? Blame Your White Matter, Vanderbilt University Study More...
More General Clinical Research News
Events

The Biomarker World Congress 2012 is dedicated to all areas of biomarker research. The meeting brings together a mix of large and medium pharmaceutical, biotech and diagnostics companies, leading universities and clinical research institutions, government and national labs, CROs, emerging companies and tool providers.

For more information visit: www.BiomarkerWorldCongress.com.
Latest Market Insight

Biomarkers in Late Stage Clinical Trials

• Quantify and analyze revenues of late stage biomarker technology and services in North America, Europe, Asia and the Rest of the World.
• Identify the key market drivers and resistors of the biomarker market and evaluate the growth potential of emerging technologies.
• Assess biomarker activity at leading companies, including Abbott, AZ, BMS, Eli Lilly, GSK, Merck & Co, Novartis, Pfizer, Roche and Sanofi-Aventis.

Click Here for More Information.
Tower: Facebook
Top Jobs
Biotech Bay (San Francisco, California)

FibroGen, Inc.
Senior Clinical Data Manager
Responsible for overseeing Data Management (DM) operational activities, ensuring compliance with the corporate timeline and scope of work outsourced to the DM service provider (SP) and coordinating activities from other external vendors that may also provide study data.

BioMidwest (Chicago, Illinois)

Takeda Pharmaceuticals
Clinical Study Manager/ Senior Clinical Study Manager
Responsible for the execution of Phase II-IV and other approved US and ex-US clinical studies, according to ICH-GCP and required regional regulations as applicable in support of the clinical strategies defined in the Takeda Integrated Development Plan (IDP).

Biotech Beach (Irvine, California)

Allergan Inc.
Senior Clinical Data Manager
Will provide specialized knowledge and detailed attention to carry out data management data review activities in support of one or more clinical research studies.

BioForest (Pacific NorthWest, Washington)

Biotecher
Senior Director Clinical Development
Directs and oversees GCP and/or ICH global clinical team activities to ensure that clinical department deliverables are met. Lead clinical design, planning, execution, and development.

Pharm Country (Bedminster, New Jersey)

Allergan Inc.
Systems Development Manager, Clinical Programming
Manage the design, development, validation, implementation, maintenance and support of electronic systems, programs, scripts and tools for clinical trial data capture (e.g., EDC Oracle Inform, IVRS, ePRO), data integration (e.g. ETL Informatica PowerCenter, SOA, PL/SQL, Oracle, Clinical Data Repository) and reporting/delivery (Business Objects, Spotfire, Sharepoint, Infopath, SDTM).

• Get Noticed! Add your resume to the BioSpace Career Center!
• See more than 5,000 job postings in the BioSpace Career Center!


Biotech Beach

Biotech Beach Career Fair

Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California area.

Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.)

Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research.

Job seekers may register here.

Biotech Beach Career Fair, La Jolla, CA April 17, 2012
BioCapital Career Fair, Bethesda, MD April 25, 2012
Pharm Country Career Fair, King Of Prussia, PA May 1, 2012
BioNC Career Fair, Durham, NC May 2, 2012
Biotech Bay Career Fair, Burlingame, CA May 29, 2012

More information about BioSpace's Career Fairs

BioSpace White Paper
Biotech Career Fairs For Job Seekers 101: Control Your Experience
By June Salvati, BioSpace Director of Events and Corporate Services
HeadHtml
•  Cerebain Biotech Announces Publication of Its Patent Application More...
•  CytRx Corporation (CYTR) Announces Issuance of Key U.S. Patent Covering INNO-206 Linker Technology More...
•  Raptor Pharmaceutical Inc. (RPTP) Receives Notices of Allowance for Key European Patent Applications Protecting Its Cysteamine Portfolio More...
•  Alitair Announces Notice of Patent Allowance for its Platform Drug Delivery Technology, REA™ More...
•  IMPAX Laboratories, Inc. (IPXL) Confirms Patent Challenge Relating to Generic GRALISE® 300 mg and 600 mg More...
More Patent News
Feature

Hot Company

Nektar Therapeutics (AL)
490 Discovery Drive
Huntsville, Alabama 35806 U.S.A.
Phone: 256-533-4201 Fax: 256-533-4805

Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its proprietary polymer conjugation technology platform. Nektar has a robust R&D pipeline of potentially high-value therapeutics in oncology, pain and other areas.

More Company Profiles
Contact Us

Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship

ClinicaSpace
6465 South Greenwood Plaza, Suite 400
Centennial, Colorado 80111 U.S.A.
Phone: 877-277-7585
Fax: 800-595-2929
ClinicaSpace
90 New Montgomery Street, Suite 414
San Francisco, California 94105 U.S.A.
Phone: 877-277-7585
Fax: 415-576-9217

Send questions and comments to the ClinicaSpace News Beat Team.

Editor & Publisher: Rosemary Do
Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong

ClinicaSpace.com - Clinical Trials. Clinical Research. Community.
Legal Notice
• ClinicaSpace is a registered trademark of BioSpace, Inc.
• Please distribute this e-cast freely.
• Credit any excerpts as follows:
Copyright 2012 ClinicaSpace http://www.clinicaspace.com
• While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes.
Subscribe/Unsubscribe
If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here.

Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.
 


No comments: